Newport Beach, Calif. – June 1, 2015 – Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Philadelphia CyberKnife (an Alliance Oncology partner facility) presented three clinical outcomes research projects at the American College of Radiation Oncology’s 25th annual meeting from May 14 – 16 in Washington, D.C.
American College of Radiation Oncology (ACRO) is the essential professional society for success in the day-to-day practice of radiation oncology. ACRO strives to ensure the highest quality care for radiation therapy patients and promote success in the practice of radiation oncology through education, responsible socioeconomic advocacy, and integration of science and technology into clinical practice.
The theme for this year’s conference was “Controversies, Collaboration and Personalized Care in Radiation Oncology” and topics covered included clinical updates, the application of advanced techniques and technologies in care, economics and political issues, clinical controversies and presentations of new outcomes research.
“We are pleased to present our data at this major national meeting for radiation and other oncology specialists,” said Rachelle M. Lanciano M.D., radiation oncologist at Philadelphia CyberKnife. “Our entire team at Philadelphia CyberKnife is committed to conducting research that will lead to a better understanding of stereotactic radiation treatment and its impact on patients’ lives.”
There are two types of presentations accepted by the society: oral and poster. In order to present, authors first had to submit a written abstract about their topic of choice. ACRO then reviewed the abstracts and chose the ones they wanted to see presented at the annual meeting.
Royce Brown, Clinical Outcomes Analyst for Philadelphia CyberKnife, and Genevieve Manahan and William R. Rate IV, volunteer students at Philadelphia CyberKnife, were the authors whose poster presentations were accepted by the society.
Royce Brown graduated from Trinity College in Hartford, Conn., where he majored in neuroscience. His research topic was titled Prognostic Index for Patients Receiving CyberKnife – delivered
Stereotactic Radiosurgery (SRS) for Second Brain Metastatic Event. His goal is to enter medical school starting a post baccalaureate program in August 2015.
Genevieve Manahan is a second year medical student at Drexel University College of Medicine in Philadelphia, Pa., and went to undergrad at University of California in Berkeley, Calif. for microbiology. Her topic was titled Is There Prognostic Value for Risk Stratification by NCCN Guidelines Version 1.2015 for Localized Prostate Cancer Treated with Stereotactic Body Radiation Therapy? Her goal is to practice radiation oncology which requires her to first finish a four year residency program.
William R. Rate IV currently attends Washington College in Chestertown, Md. He is acquiring his undergraduate as a double major in chemistry and biology with a minor in psychology. Mr. Rate’s topic was The effect of higher BEDs for optimal local control of lung metastases treated with CyberKnife SBRT. After graduation, he hopes to enter medical school.
Royce, Genevieve, and William were also presented recognition certificates from Philadelphia CyberKnife, congratulating the authors on having their posters accepted for presentation at the ACRO national meeting. Luther W. Brady M.D., Director of Medical Research, Rachelle M. Lanciano M.D., and Jun Yang PhD., DABR, were the presenters and attended the ACRO annual meeting.
About Philadelphia CyberKnife
Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System, and is an Alliance Healthcare facility. The center is located off the hospital’s main campus at 2010 West Chester Pike in Havertown, Pennsylvania. For more information about Philadelphia CyberKnife, or to determine if you or a loved one may be a CyberKnife candidate, please visit www.phillycyberknife.com or call (610) 446-6850. Most insurance plans and Medicare are accepted.
About Alliance HealthCare Services
Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services with a 30+year track record of award-winning patient care/satisfaction and service line expertise. Providing diagnostic radiology services through its Radiology Division (Alliance HealthCare Radiology), interventional radiology & pain management services through its Interventional Services Division (Alliance HealthCare Interventional Services) and radiation oncology services through its Oncology Division (Alliance Oncology), Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of March 31, 2015, Alliance operated 523 diagnostic imaging and radiation therapy systems, including 117 fixed-site imaging centers across the country; and 31 radiation therapy centers, including 19 stereotactic radiosurgery (SRS) facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 44 states where approximately 1,800 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit https://www.alliancehealthcareservices-us.com.